This recognition underscores ChromaDex's industry-leading NAD+ research and its expanding portfolio of healthy aging products featuring Niagen® (patented nicotinamide riboside or NR), the most efficient and high-quality NAD+ precursor. Such innovative products include the direct-to-consumer dietary supplement, Tru Niagen®, and the newly unveiled pharmaceutical-grade Niagen IV.
Excellence is not about meeting expectations. It is about redefining them. ChromaDex is proud to be honored on Inc. magazine’s 2024 Best in Business List in the Health Products category. Inc. Best in Business celebrates companies that push boundaries and make an indelible mark on the world.
This recognition places ChromaDex in extraordinary company. Ossium Health, a leader in stem cell innovation, and Sharebite, a platform revolutionizing food insecurity solutions, exemplify the transformative power of business done right. To join their ranks is an honor that fuels our dedication to advancing cellular health.
At the heart of our innovative product portfolio is our flagship patented nicotinamide riboside (NR) ingredient, Niagen®, a cornerstone of healthy-aging cellular science. At the foundation of our bestselling supplement Tru Niagen is Niagen®, backed by 35+ clinical studies demonstrating its safety and efficacy. Over 65% of registered ongoing or completed nicotinamide riboside (NR) trials use Niagen®, highlighting its critical role in advancing cellular health research.
As the #1 NAD+ supplement brand in the U.S., Tru Niagen leads the way in redefining how we support cellular health, empowering people to age better. Tru Niagen® delivers superior NAD+ support, energizing cells and helping to optimize mitochondrial function to elevate overall wellness to its highest potential.
“Our mission is to help people around the world to age better, and this honor reflects the progress we’re making toward achieving that goal,” said ChromaDex CEO and Founder of Tru Niagen, Rob Fried.